123 related articles for article (PubMed ID: 36960857)
21. VAV3 mediates resistance to breast cancer endocrine therapy.
Aguilar H; Urruticoechea A; Halonen P; Kiyotani K; Mushiroda T; Barril X; Serra-Musach J; Islam A; Caizzi L; Di Croce L; Nevedomskaya E; Zwart W; Bostner J; Karlsson E; Pérez Tenorio G; Fornander T; Sgroi DC; Garcia-Mata R; Jansen MP; García N; Bonifaci N; Climent F; Soler MT; Rodríguez-Vida A; Gil M; Brunet J; Martrat G; Gómez-Baldó L; Extremera AI; Figueras A; Balart J; Clarke R; Burnstein KL; Carlson KE; Katzenellenbogen JA; Vizoso M; Esteller M; Villanueva A; Rodríguez-Peña AB; Bustelo XR; Nakamura Y; Zembutsu H; Stål O; Beijersbergen RL; Pujana MA
Breast Cancer Res; 2014 May; 16(3):R53. PubMed ID: 24886537
[TBL] [Abstract][Full Text] [Related]
22. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
[TBL] [Abstract][Full Text] [Related]
23. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
Ji Y; Sun Q; Zhang J; Hu H
Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
[TBL] [Abstract][Full Text] [Related]
24. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S
BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
27. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
Peacock SO; Fahrenholtz CD; Burnstein KL
Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
[TBL] [Abstract][Full Text] [Related]
28. Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.
Magani F; Peacock SO; Rice MA; Martinez MJ; Greene AM; Magani PS; Lyles R; Weitz JR; Burnstein KL
Mol Cancer Res; 2017 Nov; 15(11):1469-1480. PubMed ID: 28811363
[TBL] [Abstract][Full Text] [Related]
29. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T
Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460
[TBL] [Abstract][Full Text] [Related]
30. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
[TBL] [Abstract][Full Text] [Related]
31. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
Reimer D; Boesch M; Wolf D; Marth C; Sopper S; Hatina J; Altevogt P; Parson W; Hackl H; Zeimet AG
Int J Cancer; 2018 Apr; 142(8):1640-1651. PubMed ID: 29194596
[TBL] [Abstract][Full Text] [Related]
32. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑876‑5p inhibits the progression of glioblastoma multiforme by directly targeting Forkhead box M1.
Wang L; Lu J; Zhang H; Lyu X; Sun Z
Oncol Rep; 2019 Jan; 41(1):702-710. PubMed ID: 30365126
[TBL] [Abstract][Full Text] [Related]
34. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
[TBL] [Abstract][Full Text] [Related]
35. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
36. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
37. LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal.
Gao X; Mi Y; Ma Y; Jin W
Tumour Biol; 2014 Nov; 35(11):11505-11. PubMed ID: 25128061
[TBL] [Abstract][Full Text] [Related]
38. Differential Gene Expression of the Proto-oncogene VAV3 and the Transcript Variant VAV3.1 in Oral Squamous Cell Carcinoma.
Trenkle T; Hakim SG; Jacobsen HC; Sieg P
Anticancer Res; 2015 May; 35(5):2593-600. PubMed ID: 25964534
[TBL] [Abstract][Full Text] [Related]
39. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
40. miR-340 suppresses glioblastoma multiforme.
Huang D; Qiu S; Ge R; He L; Li M; Li Y; Peng Y
Oncotarget; 2015 Apr; 6(11):9257-70. PubMed ID: 25831237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]